rectal neoplasms

Summary

Summary: Tumors or cancer of the RECTUM.

Top Publications

  1. ncbi Preoperative versus postoperative chemoradiotherapy for rectal cancer
    Rolf Sauer
    Department of Radiation Therapy, University of Erlangen, Erlangen, Germany
    N Engl J Med 351:1731-40. 2004
  2. ncbi Chemotherapy with preoperative radiotherapy in rectal cancer
    Jean Francois Bosset
    Department of Radiation Therapy, University of Franche Comte, Besancon, France
    N Engl J Med 355:1114-23. 2006
  3. ncbi Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2
    Jean Pierre Gerard
    Centre Antoine Lacassagne, 06189 Nice Cedex 2, France
    J Clin Oncol 28:1638-44. 2010
  4. ncbi Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03
    Mark S Roh
    National Surgical Adjuvant Breast and Bowel Project NSABP Operations Cente, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA
    J Clin Oncol 27:5124-30. 2009
  5. ncbi Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
    Monique Maas
    Department of Surgery, Maastricht University Medical Centre, Maastricht, Netherlands
    Lancet Oncol 11:835-44. 2010
  6. ncbi The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
    Koen C M J Peeters
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Ann Surg 246:693-701. 2007
  7. ncbi Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
    Vincenzo Valentini
    Cattedra di Radioterapia, Universita Cattolica del Sacro Cuore, Policlinico Universitario A Gemelli, Largo Gemelli 8, Rome, Italy
    Radiother Oncol 92:148-63. 2009
  8. ncbi Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
    Jean Pierre Gerard
    Centre Antoine Lacassagne, Radiotherapy Department, Nice, France
    J Clin Oncol 24:4620-5. 2006
  9. ncbi Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis
    Shandra Bipat
    Department of Radiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Radiology 232:773-83. 2004
  10. ncbi Guidelines 2000 for colon and rectal cancer surgery
    H Nelson
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Natl Cancer Inst 93:583-96. 2001

Research Grants

  1. Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2010
  2. FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDY
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2003
  3. DIET, ACTIVITY & REPRODUCTION--RISKS FOR RECTAL CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2002
  4. Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2010
  5. Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2007
  6. DIET AND SOMATIC MUTATIONS IN COLON CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2007
  7. Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2009
  8. A PROSPECTIVE STUDY OF ALASKA NATIVES & AMERICAN INDIANS
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2006
  9. Growth Factors and Colon Cancer
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2006
  10. DIET AND SOMATIC MUTATIONS IN COLON CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 1999

Detail Information

Publications246 found, 100 shown here

  1. ncbi Preoperative versus postoperative chemoradiotherapy for rectal cancer
    Rolf Sauer
    Department of Radiation Therapy, University of Erlangen, Erlangen, Germany
    N Engl J Med 351:1731-40. 2004
    ..In recent years, encouraging results with preoperative radiotherapy have been reported. We compared preoperative chemoradiotherapy with postoperative chemoradiotherapy for locally advanced rectal cancer...
  2. ncbi Chemotherapy with preoperative radiotherapy in rectal cancer
    Jean Francois Bosset
    Department of Radiation Therapy, University of Franche Comte, Besancon, France
    N Engl J Med 355:1114-23. 2006
    ..Preoperative radiotherapy is recommended for selected patients with rectal cancer. We evaluated the addition of chemotherapy to preoperative radiotherapy and the use of postoperative chemotherapy in the treatment of rectal cancer...
  3. ncbi Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2
    Jean Pierre Gerard
    Centre Antoine Lacassagne, 06189 Nice Cedex 2, France
    J Clin Oncol 28:1638-44. 2010
    ..Neoadjuvant chemoradiotherapy is considered a standard approach for T3-4 M0 rectal cancer. In this situation, we compared neoadjuvant radiotherapy plus capecitabine with dose-intensified radiotherapy plus capecitabine and oxaliplatin...
  4. ncbi Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03
    Mark S Roh
    National Surgical Adjuvant Breast and Bowel Project NSABP Operations Cente, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA
    J Clin Oncol 27:5124-30. 2009
    ..The NSABP R-03 (National Surgical Adjuvant Breast and Bowel Project R-03) trial compared neoadjuvant versus adjuvant chemoradiotherapy in the treatment of locally advanced rectal carcinoma...
  5. ncbi Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
    Monique Maas
    Department of Surgery, Maastricht University Medical Centre, Maastricht, Netherlands
    Lancet Oncol 11:835-44. 2010
    ..This study established whether patients with pCR have better long-term outcome than do those without pCR...
  6. ncbi The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
    Koen C M J Peeters
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Ann Surg 246:693-701. 2007
    ..To investigate the efficacy of preoperative short-term radiotherapy in patients with mobile rectal cancer undergoing total mesorectal excision (TME) surgery...
  7. ncbi Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
    Vincenzo Valentini
    Cattedra di Radioterapia, Universita Cattolica del Sacro Cuore, Policlinico Universitario A Gemelli, Largo Gemelli 8, Rome, Italy
    Radiother Oncol 92:148-63. 2009
    ....
  8. ncbi Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
    Jean Pierre Gerard
    Centre Antoine Lacassagne, Radiotherapy Department, Nice, France
    J Clin Oncol 24:4620-5. 2006
    ..In 1992, preoperative radiotherapy was considered in France as the standard treatment for T3-4 rectal cancers. The present randomized trial compares preoperative radiotherapy with chemoradiotherapy...
  9. ncbi Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis
    Shandra Bipat
    Department of Radiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Radiology 232:773-83. 2004
    ..To perform a meta-analysis to compare endoluminal ultrasonography (US), computed tomography (CT), and magnetic resonance (MR) imaging in rectal cancer staging...
  10. ncbi Guidelines 2000 for colon and rectal cancer surgery
    H Nelson
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Natl Cancer Inst 93:583-96. 2001
    ..The National Cancer Institute sponsored a panel of experts to systematically review current literature and to draft guidelines that provide uniform definitions, principles, and practices...
  11. ncbi Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer
    M Caricato
    Department of Surgery, Campus Bio Medico University, Via Longoni 47, 00155 Rome, Italy
    Eur J Surg Oncol 33:724-8. 2007
    ..The purpose of this study is to analyse the TRG on mesorectal lymphnodes (lymphnode regression grade, LRG) after preoperative chemoradiation in rectal cancer patients and to determine the correlation with TRG of primary tumor...
  12. ncbi A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer
    Julie A Cornish
    Department of Biosurgery and Surgical Technology, St Mary s Hospital, Imperial College, 10th Floor QEQM Wing, Praed Street, London, W2 1NY, UK
    Ann Surg Oncol 14:2056-68. 2007
    ..The aim of this study was to compare QoL following abdominoperineal excision of rectum (APER) with that after anterior resection (AR) in patients with rectal cancer...
  13. ncbi Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
    David Sebag-Montefiore
    St James s University Hospital, Leeds, UK
    Lancet 373:811-20. 2009
    ..We compared short-course preoperative radiotherapy versus initial surgery with selective postoperative chemoradiotherapy...
  14. ncbi A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy
    G Lezoche
    Department of Surgery Paride Stefanini, II Clinica Chirurgica, University of Rome La Sapienza, Viale del Policlinico, 00161, Rome, Italy
    Surg Endosc 22:352-8. 2008
    ....
  15. ncbi Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study
    Patrick A Hein
    Department of Radiotherapy and Radiooncology, University of Innsbruck, Innsbruck, Austria
    Eur J Radiol 45:214-22. 2003
    ..To evaluate the clinical value of diffusion-weighted magnetic resonance imaging (DW-MRI) to monitor response of primary carcinoma of the rectum to preoperative chemoradiation by measuring tumor apparent diffusion coefficient (ADC)...
  16. ncbi Effective surgical adjuvant therapy for high-risk rectal carcinoma
    J E Krook
    Duluth Community Clinical Oncology Program, Minn
    N Engl J Med 324:709-15. 1991
    ..We designed a combination regimen to optimize the contribution of chemotherapy, decrease recurrence, and improve survival as compared with adjuvant radiation alone...
  17. ncbi Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
    K Bujko
    Department of Radiotherapy, Maria Sklodowska Curie Memorial Cancer Centre, Warsaw, Poland
    Br J Surg 93:1215-23. 2006
    ..The aim of this study was to compare survival, local control and late toxicity in the two treatment groups...
  18. ncbi Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
    Claus Rodel
    Department of Radiation Therapy, University of Erlangen, Universitatsstr 27, D 91054 Erlangen, Germany
    J Clin Oncol 23:8688-96. 2005
    ..We assessed the impact of tumor regression grading (TRG) and its value in correlation to established prognostic factors in a cohort of rectal carcinoma patients treated by preoperative chemoradiotherapy (CRT)...
  19. ncbi The posterior approach for low retrorectal tumors in adults
    Nicolas Buchs
    Unit of Proctology, Department of Surgery, University Hospital of Geneva, 24, Rue Micheli du Crest, 1205 Geneva, Switzerland
    Int J Colorectal Dis 22:381-5. 2007
    ..The aim of this study is to evaluate early complete surgical resection by a perineal approach as the therapy-of-choice for tumors under the sacral promontory...
  20. ncbi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients
    Vincenzo Valentini
    Department of Radiotherapy, Catholic University of the Sacred Heart, Policlinico Universitario Agostino Gemelli, Largo A Gemelli 8, 00168 Rome, Italy
    Int J Radiat Oncol Biol Phys 53:664-74. 2002
    ....
  21. ncbi Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy
    Marian Grade
    Department of General and Visceral Surgery, University Medicine, Georg August University, Robert Koch Str 40, 37075 Gottingen, Germany
    Cancer Genet Cytogenet 193:19-28. 2009
    ..This will require validation in a larger cohort of patients...
  22. ncbi Diffusion MRI for prediction of response of rectal cancer to chemoradiation
    Andrzej Dzik-Jurasz
    UK Cancer Research Clinical Magnetic Resonance Research Group, Institute of Cancer Research, Royal Marsden NHS Trust, Downs Road, Sutton SM2 5PT, UK
    Lancet 360:307-8. 2002
    ..67, p=0.01) and chemoradiation (r=-0.83, p=0.001). Persistence of low ADC in responders after chemotherapy could represent loss of a non-viable fraction of the treated tumour...
  23. ncbi PIK3CA mutations predict local recurrences in rectal cancer patients
    Youji He
    Departments of Experimental Therapy, Pathology, and Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Clin Cancer Res 15:6956-62. 2009
    ..In this study, we aim to determine the mutation frequencies of PIK3CA, KRAS, and BRAF and to investigate whether a mutation may be used as a prognostic parameter in rectal cancer patients...
  24. ncbi Molecular targeted treatment and radiation therapy for rectal cancer
    Friederike Marquardt
    Department of Radiation Therapy, University of Frankfurt Main, Germany
    Strahlenther Onkol 185:371-8. 2009
    ..An emerging strategy to improve outcomes in rectal cancer is to integrate biologically active, targeted agents as triple therapy into chemoradiation protocols...
  25. ncbi Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection
    Garrett M Nash
    Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Dis Colon Rectum 53:1365-73. 2010
    ..Negative surgical margins are important for local control of rectal cancer treated with sphincter-preserving surgery. However, the association of rectal cancer recurrence with close distal margin is not well established...
  26. ncbi The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer
    Maarten Lambrecht
    Department of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, Leuven, Belgium
    Acta Oncol 49:956-63. 2010
    ..To investigate the use of FDG-PET/CT before, during and after chemoradiotherapy (CRT) and diffusion-weighted magnetic resonance imaging (DW-MRI) before CRT for the prediction of pathological response (pCR) in rectal cancer patients...
  27. ncbi Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials
    K Bujko
    Department of Radiotherapy, The Maria Sklodowska Curie Memorial Cancer Centre, Warsaw, Poland
    Ann Oncol 21:1743-50. 2010
    ....
  28. ncbi Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial
    Carlo Aschele
    Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    J Clin Oncol 29:2773-80. 2011
    ..To investigate oxaliplatin combined with fluorouracil-based chemoradiotherapy as preoperative treatment for locally advanced rectal cancer...
  29. ncbi Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
    D Pettersson
    Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Br J Surg 97:580-7. 2010
    ..The present interim analysis assessed feasibility, compliance and complications after RT and surgery...
  30. ncbi Urinary dysfunction after rectal cancer treatment is mainly caused by surgery
    M M Lange
    Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands
    Br J Surg 95:1020-8. 2008
    ..This study aimed to evaluate UD during 5 years after total mesorectal excision (TME) and to investigate the influence of preoperative radiotherapy (PRT) and surgical factors...
  31. ncbi Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging
    Ying Shi Sun
    Key laboratory of Carcinogenesis and Translational Research, Department of Radiology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China
    Radiology 254:170-8. 2010
    ....
  32. ncbi Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex
    Robert S Krouse
    Southern Arizona Veterans Affairs Health Care System, Tucson, AZ 85723, USA
    J Clin Oncol 27:4664-70. 2009
    ..Specifying common challenges and sociodemographic or clinical differences will further the development of tailored interventions to improve health-related quality of life (HRQOL)...
  33. ncbi KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy
    Jochen Gaedcke
    Department of General and Visceral Surgery, University Medical Center, Georg August University Gottingen, Robert Koch Str 40, 37075 Gottingen, Germany
    Radiother Oncol 94:76-81. 2010
    ..KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established...
  34. ncbi Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study
    Miguel Nogue
    Department of Oncology, Hospital General de Vic, C Francesc Pla El Vigatà, 1, 08500 Vic, Spain
    Oncologist 16:614-20. 2011
    ..The objective of the current study was to assess the efficacy and toxicity of adding bevacizumab to induction chemotherapy followed by preoperative bevacizumab-based chemoradiotherapy in patients with locally advanced rectal cancer...
  35. ncbi The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection
    Sheng Xiang Rao
    Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, 200032 Shanghai, People s Republic of China
    Eur J Radiol 65:299-303. 2008
    ..To evaluate the clinical value of diffusion-weighted imaging (DWI) in combination with T(2)-weighted imaging (T(2)WI) for the detection of rectal cancer as compared with T(2)WI alone...
  36. ncbi Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy
    Angelita Habr-Gama
    Department of Gastroenterology, , , , Brazil
    J Gastrointest Surg 10:1319-28; discussion 1328-9. 2006
    ..Survival in these patients is significantly affected by systemic failure. Exclusive local failure occurs late after CRT completion and is frequently amenable to salvage therapy...
  37. ncbi Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy
    Brunella Barbaro
    Department of Bioimaging and Radiological Sciences, Catholic University, School of Medicine, Largo A Gemelli 1, 00168 Rome, Italy
    Radiographics 30:699-716. 2010
    ..Supplemental material available at http://radiographics.rsna.org/lookup/suppl/doi:10.1148/rg.303095085/-/DC1...
  38. ncbi Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial
    Peter Matthiessen
    Department of Surgery, Orebro University Hospital, Orebro, Sweden
    Ann Surg 246:207-14. 2007
    ....
  39. ncbi Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?
    Duck Woo Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
    Cancer 106:1694-700. 2006
    ..The current study investigated the correlation between tumor involvement in regional lymph nodes and rectal mural tumor status in patients who underwent preoperative CRT for rectal cancer...
  40. ncbi A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography
    Francesco Stipa
    Department of Surgery-Colorectal Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, New York 10021, USA
    Ann Surg Oncol 13:1047-53. 2006
    ..Because pCR seems to be associated with better outcome, an understanding of the factors governing the response to CMT should be pursued...
  41. ncbi Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial
    Corrie A M Marijnen
    Department of Clinical Oncology, Leiden University Medical Center, K1 P, PO Box 9600, 2300 RC Leiden, The Netherlands
    J Clin Oncol 23:1847-58. 2005
    ..This report describes the HRQL and sexual functioning of 990 patients who underwent TME and were randomly assigned to short-term PRT (5 x 5 Gy)...
  42. ncbi Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial
    Simon S M Ng
    Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Ann Surg Oncol 15:2418-25. 2008
    ..Recurrence and survival data were also recorded and compared between the two groups...
  43. ncbi Curative potential of multimodality therapy for locally recurrent rectal cancer
    Dieter Hahnloser
    Division of Colon and Rectal Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Ann Surg 237:502-8. 2003
    ..Long-term survival can be achieved, especially for patients with no symptoms and minimal fixation of the recurrence in the pelvis, provided no gross residual disease remains...
  44. ncbi Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status
    Thomas E Read
    Division of Colon and Rectal Surgery, Western Pennsylvania Hospital--Clinical Campus of Temple University School of Medicine, Pittsburgh, Pennsylvania 15224, USA
    Dis Colon Rectum 47:825-31. 2004
    ....
  45. ncbi Impact of functional results on quality of life after rectal cancer surgery
    Jaana H Vironen
    Helsinki University Central Hospital, Jorvi Hospital, Espoo, Finland
    Dis Colon Rectum 49:568-78. 2006
    ..Permanent colostomy is not always the factor that disrupts a person's quality of life most...
  46. ncbi Liver resection for colorectal metastases
    Y Fong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 15:938-46. 1997
    ..The current study was performed to determine if liver resection for colorectal metastases is safe and effective and to evaluate predictors of outcome...
  47. ncbi Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer
    O Glehen
    Department of Surgery, Centre Hospitalier Lyon-Sud, Lyons, France
    Br J Surg 90:996-8. 2003
  48. ncbi Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging
    Christian Kremser
    Department of Radiology, University of Innsbruck, Austria
    Strahlenther Onkol 179:641-9. 2003
    ..To study changes of the apparent diffusion coefficient (ADC) measured by magnetic resonance imaging (MRI) in patients with primary rectal carcinoma during a course of combined chemoradiation...
  49. ncbi Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
    Morten Braendengen
    Departments of Medical Oncology and Surgery, Norwegian Radium Hospital, Ulleval University Hospital, Cancer Centre, Oslo, Norway
    J Clin Oncol 26:3687-94. 2008
    ..This trial investigated whether chemotherapy as part of a multidisciplinary treatment approach would improve downstaging, survival, and relapse rate...
  50. ncbi Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results
    Angelita Habr-Gama
    Colorectal Surgery Division, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
    Ann Surg 240:711-7; discussion 717-8. 2004
    ..Report overall long-term results of stage 0 rectal cancer following neoadjuvant chemoradiation and compare long-term results between operative and nonoperative treatment...
  51. ncbi Laparoscopic versus open surgery for rectal cancer: a meta-analysis
    Omer Aziz
    Department of Surgical Oncology and Technology, Imperial College London, St. Mary's Hospital, 10th Floor QEQM Wing, Praed Street, London, W2 1NY, United Kingdom
    Ann Surg Oncol 13:413-24. 2006
    ..Results from randomized trials reporting long-term outcomes such as cancer recurrence (local and metastatic) and 5-year survival are eagerly awaited...
  52. ncbi Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial
    Karoline Horisberger
    Chirurgische Klinik und Poliklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 74:1487-93. 2009
    ..To evaluate the safety and efficacy of preoperative radiotherapy (RT) in combination with cetuximab, capecitabine, and irinotecan in patients with locally advanced rectal cancer...
  53. ncbi Rectal cancer radiotherapy: towards European consensus
    Vincenzo Valentini
    Cattedra di Radioterapia, Universita Cattolica S Cuore, Rome, Italy
    Acta Oncol 49:1206-16. 2010
    ..This article summarizes the consensus about imaging and radiotherapy of rectal cancer and gives an update until May 2010...
  54. ncbi Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique
    D G Jayne
    Academic Unit of Surgery, St James s University Hospital, Leeds, UK
    Br J Surg 92:1124-32. 2005
    ..Bladder and sexual dysfunction are recognized complications of mesorectal resection. Their incidence following laparoscopic surgery is unknown...
  55. ncbi Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer
    Julio Garcia-Aguilar
    Department of Surgery, City of Hope, Duarte, CA 91010, USA
    Ann Surg 254:486-92; discussion 492-3. 2011
    ..To identify a biomarker profile associated with tumor response to chemoradiation (CRT) in locally advanced rectal cancer...
  56. ncbi Management of recurrent rectal cancer
    Philippe Bouchard
    Division of Colorectal Surgery, Mayo Clinic Arizona, Scottsdale, AZ, USA
    Ann Surg Oncol 17:1343-56. 2010
    ..Here we present a concise review on the evaluation and management of locally recurrent rectal cancer, which despite marked reductions in the rate of recurrent rectal cancer remains an important problem...
  57. ncbi Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection
    Martin R Weiser
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 249:236-42. 2009
    ....
  58. ncbi Management of recurrent rectal cancer: a population based study in greater Amsterdam
    Roel Bakx
    Academic Medical Center, Department of Surgery, Meibergdreef 9, G4 137, Amsterdam AZ 1105, Netherlands
    World J Gastroenterol 14:6018-23. 2008
    ..To analyze, retrospectively in a population-based study, the management and survival of patients with recurrent rectal cancer initially treated with a macroscopically radical resection obtained with total mesorectal excision (TME)...
  59. ncbi Laparoscopic excision of retrorectal schwannoma
    P Witherspoon
    The John Goligher Department of Colorectal Surgery, The General Infirmary at Leeds, Leeds, United Kingdom
    Dis Colon Rectum 53:101-3. 2010
    ..lww.com/DCR/A29)...
  60. ncbi Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer
    Saúl E Rodríguez-Ramírez
    Colorectal Service, Surgical Oncology Department, Hospital de Oncologia, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social
    Rev Invest Clin 58:204-10. 2006
    ..Risk factors for anastomotic leakage after preoperative chemoradiation plus low anterior resection and total mesorectal excision remain uncertain...
  61. ncbi High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction
    M Kikuchi
    Department of Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Br J Cancer 101:116-23. 2009
    ..In the present study, the relation between histological response to CRT and immunohistochemical markers in biopsy specimens was investigated...
  62. ncbi Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?
    Raphaëla C Dresen
    Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands
    Radiology 252:71-80. 2009
    ....
  63. ncbi Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy
    Christiane Jakob
    Institute for Pathology, University of Technology, Fetscherstr 74, D 01307 Dresden, Germany
    World J Gastroenterol 14:1060-6. 2008
    ..To investigate the predictive value of Ki67 and p53 and their correlation with thymidylate synthase (TS) gene expression in a rectal cancer patient cohort treated according to a standardized recommended neoadjuvant treatment regimen...
  64. ncbi Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
    A De Paoli
    Department of Radiation Oncology, C R O National Cancer Institute, Aviano, Italy
    Ann Oncol 17:246-51. 2006
    ..The aim of the study was to evaluate tolerance and efficacy of preoperative treatment with capecitabine in combination with radiation therapy (RT) in patients with locally advanced, resectable, rectal cancer...
  65. ncbi Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer
    Raphaëla C Dresen
    Department of Surgery, Catharina Hospital Eindhoven, Postbox 1350, 5602 ZA, Eindhoven, The Netherlands
    Ann Surg Oncol 15:1937-47. 2008
    ..This study assessed the outcome of LRRC patients treated with multimodality treatment, consisting of neoadjuvant radio (chemo-) therapy, extended resection, and intraoperative radiotherapy...
  66. ncbi Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer
    Axel Kleespies
    Department of Surgery, Klinikum Grosshadern, University of Munich LMU, Marchioninistrasse 15, 81377 Munich, Germany
    Int J Colorectal Dis 24:1097-109. 2009
    ..The benefit of elective primary tumor resection for non-curable stage IV colorectal cancer (CRC) remains largely undefined. We wanted to identify risk factors for postoperative complications and short survival...
  67. ncbi Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer
    E Urso
    Clinica Chirurgica II, Dipartimento di Scienze Oncologiche e Chirurgiche, , Policlinico, VI piano, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 32:1201-8. 2006
    ..Studies on larger series are required to confirm these results...
  68. ncbi Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer
    A Suppiah
    Academic Surgical Unit, Castle Hill Hospital, Cottingham, East Yorkshire, United Kingdom
    Colorectal Dis 11:249-53. 2009
    ..Neoadjuvant therapy is increasingly used in rectal cancer and MRI is used to stage response and occasionally plan surgery. We aim to assess the staging accuracy of MRI following chemoradiotherapy in rectal cancer...
  69. ncbi Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006
    M A G Elferink
    Department of Research, Comprehensive Cancer Centre North East, Enschede Groningen, The Netherlands
    Eur J Cancer 46:1421-9. 2010
    ..Since the 1990s, treatment of patients with rectal cancer has changed in the Netherlands. Aim of this study was to describe these changes in treatment over time and to evaluate their effects on survival...
  70. ncbi Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy
    Li Jen Kuo
    Division of Colorectal Surgery, Department of Surgery, Koo Foundation Sun Yat Sen Cancer Center Hospital, Taipei, Taiwan
    Dis Colon Rectum 48:23-8. 2005
    ..The purpose of this study is to determine the accuracy of staging with magnetic resonance imaging and to define any factors that interfere in interpretation of images obtained after preoperative chemoradiation therapy...
  71. ncbi The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer
    Fabio Maria Vecchio
    Department of Pathology, Catholic University of the Sacred Heart, Rome, Italy
    Int J Radiat Oncol Biol Phys 62:752-60. 2005
    ....
  72. ncbi Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer
    Christiane Jakob
    Institute for Pathology, University of Technology, Fetscherstrasse 74, D 01307 Dresden, Germany
    J Pathol 204:562-8. 2004
    ..Moreover, intra-tumoural TS- and TP-gene expression in surgical rectal specimens after neo-adjuvant chemoradiotherapy correlates significantly with histopathological tumour regression when microdissection is applied...
  73. ncbi Randomized clinical trial comparing loop ileostomy and loop transverse colostomy for faecal diversion following total mesorectal excision
    W L Law
    Department of Surgery, Queen Mary Hospital, University of Hong Kong Medical Centre, 102 Pokfulam Road, Hong Kong
    Br J Surg 89:704-8. 2002
    ..01). CONCLUSION: Intestinal obstruction and ileus are more common after loop ileostomy than loop colostomy. Loop transverse colostomy should be recommended as the preferred method of proximal faecal diversion...
  74. ncbi Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET
    Carlo Capirci
    Radiotherapy Department, S Maria della Misericordia Rovigo Hospital, ASL 18, Rovigo, Italy
    Biomed Pharmacother 58:451-7. 2004
    ....
  75. ncbi Transanal endoscopic microsurgical excision of rectal tumors: indications and results
    N Demartines
    Department of Surgery, University Hospital of Basel, Spitalstrasse 21, CH 4031 Basel, Switzerland
    World J Surg 25:870-5. 2001
    ..5 days) make this technique a reliable and in some cases more effective surgical approach than laparotomy and low anterior resection...
  76. ncbi [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma]
    Shu mei Jiang
    Department of Radiation Oncology, Shandong Cancer Hospital, Jinan 250117, China
    Zhonghua Zhong Liu Za Zhi 30:602-5. 2008
    ..To investigate the correlation of expression of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (Ki67) with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma...
  77. ncbi Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer
    Quido G de Lussanet
    Department of Radiology, Maastricht University Hospital, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 63:1309-15. 2005
    ..This study evaluated radiation therapy related microvascular changes in locally advanced rectal cancer by DCE-MRI and histology...
  78. ncbi Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer
    Hee Chul Park
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 75:775-81. 2009
    ..To investigate whether symptom burden before and during preoperative chemoradiation therapy (CRT) for rectal cancer predicts for pathologic tumor response...
  79. ncbi Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer
    Dae Yong Kim
    Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
    Int J Radiat Oncol Biol Phys 67:378-84. 2007
    ..To describe our experience with a bolus injection of 5-fluorouracil and leucovorin (FL) vs. capecitabine in terms of radiologic and pathologic findings in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer...
  80. ncbi Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas
    Matthew F Kalady
    Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio, USA
    Dis Colon Rectum 52:1039-45. 2009
    ..This study evaluated the disparity in neoplastic changes between colon and rectal cancers...
  81. ncbi Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial
    Lucyna Pietrzak
    Department of Radiotherapy, Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
    Radiother Oncol 84:217-25. 2007
    ..The aim of this report is to find out whether large doses per fraction of short-course schedule result in more severe anorectal and sexual dysfunction and quality of life (QoL) impairment...
  82. ncbi A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit
    Arne Wibe
    University Hospital Trondheim, Trondheim, Norway
    Dis Colon Rectum 45:857-66. 2002
    ..CONCLUSION: A refinement of the surgical resection technique for rectal cancer can be achieved on a national level, the technique of total mesorectal excision can be widely distributed, and surgery alone can give good results...
  83. ncbi Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy
    Seung Ho Kim
    Department of Radiology, Seoul National University College of Medicine, Chongno Gu, Seoul 110 744, Korea
    Radiology 253:116-25. 2009
    ....
  84. ncbi Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
    F V Negri
    U O Oncologia Medica, Azienda Ospedaliero Universitaria di Parma, Via Gramsci, Parma 43100, Italy
    Br J Cancer 98:143-7. 2008
    ..Thymidylate synthase expression assessed immunohistochemically from pretreatment tumour biopsies may be a useful predictive marker of rectal tumour response to preoperative RCT...
  85. ncbi Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial
    C A M Marijnen
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Int J Radiat Oncol Biol Phys 55:1311-20. 2003
    ..Here we evaluate the effect of radiotherapy on local recurrence rates in patients with different CRM involvements...
  86. ncbi Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
    Phil Quirke
    Leeds University, Leeds, UK
    Lancet 373:821-8. 2009
    ..However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved...
  87. ncbi Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer
    Nuh N Rahbari
    Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany
    Surgery 147:339-51. 2010
    ..The aim of the present article was to propose a definition and severity grading of anastomotic leakage after anterior rectal resection...
  88. ncbi Neoadjuvant chemoradiation treatment impairs accuracy of MRI staging in rectal carcinoma
    J Jonas
    Gut 55:1214-5. 2006
  89. ncbi Postoperative complications following surgery for rectal cancer
    Bogdan C Paun
    Department of Surgery, University of Calgary, Alberta, Canada
    Ann Surg 251:807-18. 2010
    ..This systematic review was designed to determine postoperative complication rates of radical surgery for rectal cancer (abdominal perineal resection and anterior resection)...
  90. ncbi Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up
    Thilo Sprenger
    Department of General and Visceral Surgery, University Medical Center Gottingen, Georg August University, Robert Koch Str 40, 37099 Gottingen, Germany
    J Gastrointest Surg 14:96-103. 2010
    ..The objective of this prospective study was to determine the effects of chemoradiation on mesorectal lymph node retrieval under terms of a meticulous histopathological evaluation...
  91. ncbi Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer
    Miranda Kusters
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Int J Radiat Oncol Biol Phys 75:1444-9. 2009
    ..To analyze results of multimodality treatment in relation to subsite of locally recurrent rectal cancer (LRRC)...
  92. ncbi Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment
    W van Gijn
    Department of Surgery, Leiden University Medical Center, K6 R, P O Box 9600, 2300 RC Leiden, The Netherlands
    Eur J Surg Oncol 36:340-4. 2010
    ..The aim of this study is to examine the effects of the structural changes in rectal cancer care on survival compared to colon cancer for patients treated before, during and after the TME trial...
  93. ncbi Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001
    Rosemary D Cress
    California Cancer Registry, Public Health Institute, Sacramento, 95815, USA
    Cancer 107:1142-52. 2006
    ..We evaluated recent trends in colorectal cancer incidence in the United States by subsite and stage at diagnosis...
  94. ncbi Laparoscopic rectal resection for cancer: effects of conversion on short-term outcome and survival
    Matteo Rottoli
    General Surgery III, University of Milan, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy
    Ann Surg Oncol 16:1279-86. 2009
    ..The impact of conversion to open surgery on outcomes has not been fully elucidated. The aim of the study is to compare short- and long-term outcomes of converted (CR) and not converted (NCR) patients undergoing LRR...
  95. ncbi Gastrointestinal stromal tumour of the rectum: report of a case and review of literature
    Nello Grassi
    Department of Oncology, Division of General and Oncological Surgery, University of Palermo, Via del Vespro 129, Palermo 90127, Italy
    World J Gastroenterol 14:1302-4. 2008
    ....
  96. ncbi Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin
    Alejandro De la Torre
    Department of Radiation Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain
    Int J Radiat Oncol Biol Phys 70:102-10. 2008
    ..To compare, in a randomized trial, 5-fluorouracil (FU) plus leucovorin (LV) (FU+LV) vs. oral uracil and tegafur (UFT) plus LV (UFT+LV) given concomitantly with preoperative irradiation in patients with cT3-4 or N+ rectal cancer...
  97. ncbi A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer
    Yulia Kundel
    Institute of Oncology, Cancer Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Anticancer Res 27:2877-80. 2007
    ..Neoadjuvant chemoradiation with continuous infusion (CI) of 5-fluorouracil (5FU) is widely used in rectal cancer. The aim of this study was to evaluate the use of oral tegafur-uracil (UFT) and leucovorin (LV) instead of CI 5FU...
  98. ncbi Practice parameters for the management of rectal cancer (revised)
    Joe J Tjandra
    Fletcher Allen Health Care, 111 Colchester Avenue, Fletcher 301, Burlington, Vermont 05401, USA
    Dis Colon Rectum 48:411-23. 2005
    ..The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all of the circumstances presented by the individual patient...
  99. ncbi Recent advances in the treatment of localized rectal cancer
    Jean Francois Bosset
    Department of Radiation Oncology, Besancon University Hospital, Boulevard Fleming, F 25030 Besancon Cedex, France
    Curr Oncol Rep 10:220-4. 2008
    ....
  100. ncbi Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors
    Karen Lise G Spindler
    Department of Oncology, Vejle Hospital, Vejle, Denmark
    Dis Colon Rectum 50:1363-9. 2007
    ..This study was designed to investigate the predictive value of a new combination of three gene polymorphisms: thymidylate synthase, epidermal growth factor receptor Sp1-216, and epidermal growth factor A61G...
  101. ncbi [Factors affecting the prognosis and selection of local excision for low rectal cancer]
    Jian Wei Hang
    Department of Abdominal Surgical Oncology, Cancer Hospital Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
    Zhonghua Zhong Liu Za Zhi 29:141-3. 2007
    ..To investigate the factors affecting the result and selection of local excision for low rectal cancer...

Research Grants78

  1. Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2010
    ..Identification of polymorphisms or haplotypes that are relevant to colorectal cancer will advance our understanding of etiology, may lead to specific health recommendations, and can identify targets for drug therapy. ..
  2. FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDY
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2003
    ..C-peptide, glycosylated hemoglobin, IGF-1, and IGFBP3 will be evaluated with respect to breast and endometrial cancer in a subset of women. ..
  3. DIET, ACTIVITY & REPRODUCTION--RISKS FOR RECTAL CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2002
    ..abstract_text> ..
  4. Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2010
    ..The contrast between high and low risk populations will enhance this effort in a cost-efficient manner. Results could identify potential targets for drug therapy. ..
  5. Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2007
    ..Identification of polymorphisms or haplotypes that are relevant to colorectal cancer will advance our understanding of etiology, may lead to specific health recommendations, and can identify targets for drug therapy. ..
  6. DIET AND SOMATIC MUTATIONS IN COLON CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2007
    ..e. p53, K-ras, and microsatellite instability). Differences in colon and rectal tumors will be compared. Additionally data from rectal tumors will be combined with that from colon tumors to define disease pathways. ..
  7. Disparities in Breast Cancer: Development and Survival in Hispanic and NHW Women
    MARTHA OR MARTY L SLATTERY; Fiscal Year: 2009
    ..The contrast between high and low risk populations will enhance this effort in a cost-efficient manner. Results could identify potential targets for drug therapy. ..
  8. A PROSPECTIVE STUDY OF ALASKA NATIVES & AMERICAN INDIANS
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2006
    ..The AIAN cohort will serve as a resource to enhance research and training activities of AIAN students interested in health research, health education, and general public health. ..
  9. Growth Factors and Colon Cancer
    MARTHA OR MARTY SLATTERY; Fiscal Year: 2006
    ..This study builds on a unique existing resource to study genetic and environmental associations with colorectal cancer. It will provide insight into colon cancer etiology and therefore avenues to disease prevention. ..
  10. DIET AND SOMATIC MUTATIONS IN COLON CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 1999
    ..We also will store DNA frpom tumor tissue so that as laboratory techniques for analyzing somatic gene mutations necome refined, the associations between dietary intake and other genes, such as APC and DCC, can be assessed in the future. ..
  11. DIET, ACTIVITY & REPRODUCTION AS RISKS FOR COLON CANCER
    MARTHA OR MARTY SLATTERY; Fiscal Year: 1993
    ..Methods have been developed to ensure coordination of study activities...
  12. EST. INVESTIGATOR CAREER AWARD IN PREVENTION, CONTROL BEHAVIORAL & POPULATION RES
    Noel Weiss; Fiscal Year: 2006
    ..Based on past experience, these faculty will be located both within and outside the University of Washington. ..
  13. Timing of Rectal Cancer Response to Chemoradiation
    Julio Garcia Aguilar; Fiscal Year: 2009
    ..This information will help develop molecular assays to diagnose pathologic complete response in transrectal biopsies of the tumor bed before removing the rectum. ..
  14. Use of Geographic Variations to Estimate Effectiveness with Non-Randomized Data
    Mary Beth Landrum; Fiscal Year: 2010
    ..In addition, the methods developed will be applicable to a broad range of interventions for cancer and other diseases, providing a framework for future comparative effectiveness studies and ultimately changes in treatment guidelines. ..
  15. PET IMAGING IN MULTIMODALITY MANAGEMENT OF RECTAL CANCER
    Jose Guillem; Fiscal Year: 2001
    ..abstract_text> ..
  16. Radiation-induced signaling and treatment resistance
    BERT O NEIL; Fiscal Year: 2007
    ..The long-term goal of our research is to apply drugs that target tumor but not normal tissue in addition to radiation to improve the effectiveness of radiation on rectal cancer. ..
  17. Enhancing Colorectal Cancer Screening in Primary Care
    Electra D Paskett; Fiscal Year: 2010
    ..If successful, this program can easily be adapted for use by primary care practices and clinics to improve CRC screening. ..
  18. Evaluation of Biliary Strictures by IDUS, DIA, and FISH
    Michael Levy; Fiscal Year: 2005
    ..Significance: The study results have the potential to significantly improve the accurate diagnosis of biliary strictures. Earlier and more definitive diagnosis will translate into improved treatment options. ..
  19. Longitudinal Neuroimaging in Sturge-Weber Syndrome
    Csaba Juhasz; Fiscal Year: 2010
    ..The results will introduce novel, more accurate diagnostic tests and also identify new therapeutic targets to improve the outcome of this often devastating disease. ..
  20. International Conference on Malignant Bowel Obstruction
    Robert Krouse; Fiscal Year: 2004
    ..Using MBO as a model, a consensus will be attained for methodological approaches and the implementation of palliative care research. ..
  21. HR-QOL in Colorectal Cancer Survivors with Stomas
    Robert Krouse; Fiscal Year: 2006
    ..The final step will be to convene provider investigators to make recommendations for future interventions and dissemination methods based upon study findings. ..
  22. Replication Study of Breast Cancer Susceptibility Genes in Blacks
    Dezheng Huo; Fiscal Year: 2009
    ..This study will advance understanding the genetic risk factors for breast cancer in women of African descent and will be invaluable in developing novel prevention strategies in the future. ..
  23. HR-QOL in Colorectal Cancer Survivors with Stomas
    Robert Krouse; Fiscal Year: 2009
    ....